Legal Representation
Attorney
Jenevieve Maerker, Esq.
USPTO Deadlines
Next Deadline
896 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220607)
Due Date
June 07, 2028
Grace Period Ends
December 07, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 7, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 7, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 5, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| May 4, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 3, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 25, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 25, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 20, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 19, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 12, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Oct 18, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 12, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 12, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 12, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 12, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 13, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 9, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 9, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 9, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 18, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 16, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 16, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 16, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 25, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 23, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 23, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 23, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 23, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 17, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 4, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 4, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 31, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 24, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 22, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Jun 22, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Jun 22, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Jun 21, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 15, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 13, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for human use for treatment of oncological diseases and/or disorders; house mark for pharmaceutical preparations, namely, pharmaceuticals for treatment of oncological diseases and/or disorders
First Use Anywhere:
20210400
First Use in Commerce:
20210400
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"